Hair Loss News

Navigation

Hair Loss News Archives


March 2013

140 Actions Currently Pending in the Propecia Multi-District Litigation


AttorneyOne.com, a recognized authority on law, updated the website recently and is now actively providing expert opinion in view of the recent news on Propecia lawsuits.

propecia hair loss cure

According to court data updated on March 5th, 2013, by the US Judicial Panel on Multi-District Litigation (MDL), there are 140 actions pending in the Propecia MDL (U.S. District Court, Eastern District of New York, MDL 2331 - IN RE: Propecia (Finasteride) Products Liability Litigation).

Propecia is a pill, manufactured by Merck, for use in males only and indicated for the treatment of male pattern hair loss.

It was approved by the FDA in 1997. Plaintiffs claim that Merck failed to warn on Propecia side effects that could cause permanent and devastating sexual dysfunction.

On February 5th, 2013, an Illinois man filed a lawsuit in Pennsylvania Eastern District Court (case no. 2:2013cv00659) alleging that Propecia can lead to serious side effects such as sexual dysfunction.

Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Propecia severe complications.

Sean Burke, director of Media Relations for AttorneyOne.com, adds that the relevant information illustrates that people continue to file Propecia lawsuits. "For that reason", he continues, "our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

In April 2012, safety labeling changes were approved by the FDA concerning Propecia adverse events (last updated May 23rd, 2012):

Sexual dysfunction that continued after discontinuation of treatment, including erectile dysfunction, libido disorders, ejaculation disorders, and orgasm disorders; male infertility and/or poor seminal quality.

Source